CRM
ZBH icon

Cramer Rosenthal McGlynn’s Zimmer Biomet ZBH Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-99,113
Closed -$9.98M – 139
2018
Q4 		$9.98M Sell
99,113
-262,447
-73% -$29.5M 0.25% 105
2018
Q3 		$46.1M Sell
361,560
-206,310
-36% -$24.5M 0.88% 50
2018
Q2 		$61.4M Buy
567,870
+5,931
+1% +$646K 1.1% 34
2018
Q1 		$59.5M Buy
561,939
+78,957
+16% +$9.17M 0.97% 41
2017
Q4 		$56.6M Sell
482,982
-219,531
-31% -$24.8M 0.91% 43
2017
Q3 		$79.9M Buy
702,513
+442,525
+170% +$51.1M 1.28% 20
2017
Q2 		$32.4M Sell
259,988
-77,470
-23% -$9.18M 0.5% 86
2017
Q1 		$40M Buy
337,458
+26,744
+9% +$3.03M 0.61% 73
2016
Q4 		$31.1M Buy
310,714
+196,380
+172% +$21M 0.46% 90
2016
Q3 		$14.4M Buy
114,334
+1,542
+1% +$191K 0.22% 143
2016
Q2 		$13.2M Sell
112,792
-54,593
-33% -$6.18M 0.21% 144
2016
Q1 		$17.3M Buy
167,385
+22,778
+16% +$2.2M 0.27% 119
2015
Q4 		$14.4M Buy
144,607
+84,826
+142% +$8.3M 0.22% 132
2015
Q3 		$5.45M Buy
+59,781
New +$5.99M 0.07% 178

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cramer Rosenthal McGlynn's ZBH Position: Q1 2019 in Review

Cramer Rosenthal McGlynn sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 99,113 shares — an estimated $9.98M sold.

Cramer Rosenthal McGlynn first reported a position in ZBH in Q3 2015 and held it in 14 quarters. The position peaked at $79.9M in Q3 2017. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

  • Cramer Rosenthal McGlynn reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 99,113 Zimmer Biomet shares in Q1 2019, an estimated $9.98M.
  • Cramer Rosenthal McGlynn first reported a position in Zimmer Biomet in Q3 2015 and held it in 14 quarters.
  • Cramer Rosenthal McGlynn's Zimmer Biomet position peaked at $79.9M in Q3 2017.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2019, filed 14 May 2019.